Christelle Jan

发表

Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist.

S. Pierrou, M. Bossart, Michael Wagner, 2021, Cell metabolism.

A phase I trial assessing the safety, pharmacokinetics, cerebrospinal fluid penetrance, and food effect of BTK inhibitor tolebrutinib in healthy volunteers

O. Vitse, Patrick Soubayrol, M. Cabanis, 2024, Clinical and Translational Science.